Pre-IPO Bio-Thera Solutions - Insights on Pipeline and the Competitive Landscape
This article summarized the insights on major products of Bio-Thera Solutions in the pipeline and related competitive landscape with other key...
548 Views
What HKEX Biotech "Step-Ups" Can Tell Us
This Insight explains the concept of valuation "step-ups" for pre-revenue biotechnology companies listing on the HKEX and how to use this data to...
582 Views
ECM Weekly (11 October 2020) - Excellence Comm, MR DIY, Converge ICT, Simcere, SciClone, JW Thera
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming...
602 Views
JHBP/Genor (ååēē©) IPO Trading: Visible Upsides
JHBP/Genor raised HKD 2,694 million (USD 348 m) from its global offering and will list on the Hong Kong Stock Exchange tomorrow. In our previous...
518 Views
Gilead: Will Immunomedics Be Gileadās Next Pharmasset?
Gilead Sciences announced on 13th September that it has entered into a definitive agreement to acquire Immunomedics for US$88.00 per share in cash,...
530 Views